Table 1.
General study characteristics by screening test type (n=16)*
| Breast | Colon | Cervical | Multiple | TOTAL | ||
|---|---|---|---|---|---|---|
| Cancer site | 4 | 3 | 7 | 2 | 16 | |
| Mechanism | R01 | 1 | 1 | 5 | 1 | 8 |
| R21 | 2 | 2 | 1 | 0 | 5 | |
| U01 | 1 | 0 | 0 | 1 | 2 | |
| R03 | 0 | 0 | 1 | 0 | 1 | |
| Care type | Detection | 3 | 3 | 6 | 1 | 13 |
| Diagnosis | 4 | 3 | 6 | 2 | 15 | |
| Treatment | 0 | 0 | 3 | 0 | 3 | |
| Follow-up criterion |
Time to diagnostic test follow-up | 2 | 0 | 2 | 1 | 5 |
| Completion of recommended additional tests |
0 | 1 | 3 | 1 | 5 | |
| Results reported to MD/practice | 0 | 1 | 0 | 1 | 2 | |
| Test result reported to patient | 0 | 0 | 1 | 1 | 2 | |
| Diagnosis | 0 | 0 | 1 | 2 | 3 | |
| Time to diagnosis | 0 | 0 | 0 | 1 | 1 | |
| Appropriateness of follow-up | 1 | 1 | 0 | 0 | 2 | |
*
For some characteristics, the total number may be more than 16 studies, because of multiple responses.